Big mitogen-activated protein kinase 1 (BMK1)/extracellular signal regulated kinase 5 (ERK5) is involved in platelet-derived growth factor (PDGF)-induced vascular smooth muscle cell migration

Hypertension Research

Volumn 30, Issue 11, 2007, Pages 1107-1117

  Izawa, Yuki ^a   Yoshizumi, Masanori ^b   Ishizawa, Keisuke ^a   Fujita, Yoshiko ^a   Kondo, Shuji ^a   Kagami, Shoji ^a   Kawazoe, Kazuyoshi ^c   Tsuchiya, Koichiro ^a   Tomita, Shuhei ^d   Tamaki, Toshiaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Big mitogen activated protein kinase 1 extracellular signal regulated kinase 5; Platelet derived growth factor; Src homology 2 containing protein tyrosine phophatase 2; Vascular remodeling; Vascular smooth muscle cells

Indexed keywords

ADENOVIRUS VECTOR; BINDING PROTEIN; GRB2 ASSOCIATED BINDER 1 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE 5; MITOGEN ACTIVATED PROTEIN KINASE KINASE 5ALPHA; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIOVASCULAR DISEASE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMORAL ARTERY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN PROTEIN INTERACTION; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL MOVEMENT; HUMANS; MALE; MAP KINASE KINASE 5; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 7; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHOPROTEINS; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; RATS;

EID: 37849002865     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.1107     Document Type: Article

References (47)

1. Lee JD, Ulevitch RJ, Han J: Primary structure of BMK1: a new mammalian map kinase. Biochem Biophys Res Commun 1995; 213: 715-724.
2. Hayashi M, Kim SW, Imanaka-Yoshida K, et al: Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J Clin Invest 2004; 113: 1138-1148.
3. Hayashi M, Lee JD: Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice. J Mol Med 2004; 82: 800-808.
4. Suzaki Y, Yoshizumi M, Kagami S, et al: BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions. Kidney Int 2004; 65: 1749-1760.
5. Ikeda Y, Aihara K, Sato T, et al: Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis. J Biol Chem 2005; 280: 29661-29666.
6. Abe J, Kusuhara M, Ulevitch RJ, Berk BC, Lee JD: Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J Biol Chem 1996; 271: 16586-16590.
7. Suzaki Y, Yoshizumi M, Kagami S, et al: Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells: potential role in cell survival following oxidative insults. J Biol Chem 2002; 277: 9614-9621.
8. Barros JC, Marshall CJ: Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton. J Cell Sci 2005; 118: 1663-1671.
9. Hii CS, Anson DS, Costabile M, Mukaro V, Dunning K, Ferrante A: Characterization of the MEK5-ERK5 module in human neutrophils and its relationship to ERK1/ERK2 in the chemotactic response. J Biol Chem 2004; 279: 49825-49834.
10. Karihaloo A, O'Rourke DA, Nickel C, Spokes K, Cantley LG: Differential MAPK pathways utilized for HGF- and EGF-dependent renal epithelial morphogenesis. J Biol Chem 2001; 276: 9166-9173.
11. Pi X, Yan C, Berk BC: Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis. Circ Res 2004; 94: 362-369.
12. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
13. Cunningham KS, Gotlieb AI: The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest 2005; 85: 9-23.
14. Touyz RM: Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp Physiol 2005; 90: 449-455.
15. Mason DP, Kenagy RD, Hasenstab D, et al: Matrix metallo-proteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 1999; 85: 1179-1185.
16. Kishi K, Muramatsu M, Jin D, et al: The effects of chymase on matrix metalloproteinase-2 activation in neointimal hyperplasia after balloon injury in dogs. Hypertens Res 2007; 30: 77-83.
17. Yamamoto Y, Ogino K, Igawa G, et al: Allopurinol reduces neointimal hyperplasia in the carotid artery ligation model in spontaneously hypertensive rats. Hypertens Res 2006; 29: 915-921.
18. Grotendorst GR, Seppa HE, Kleinman HK, Martin GR: Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Natl Acad Sci U S A 1981; 78: 3669-3672.
19. Bilato C, Pauly RR, Melillo G, et al: Intracellular signaling pathways required for rat vascular smooth muscle cell migration. Interactions between basic fibroblast growth factor and platelet-derived growth factor. J Clin Invest 1995; 96: 1905-1915.
20. Zhan Y, Kim S, Izumi Y, et al: Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler Thromb Vasc Biol 2003; 23: 795-801.
21. Baxter RM, Secrist JP, Vaillancourt RR, Kazlauskas A: Full activation of the platelet-derived growth factor beta-receptor kinase involves multiple events. J Biol Chem 1999; 273: 17050-17055.
22. Ronnstrand L, Arvidsson AK, Kallin A, et al: SHP-2 binds to Tyr763 and Tyr1009 in the PDGF beta-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis. Oncogene 1999; 18: 3696-3702.
23. Saito Y, Hojo Y, Tanimoto T, Abe J, Berk BC: Protein kinase C-alpha and protein kinase C-epsilon are required for Grb2-associated binder-1 tyrosine phosphorylation in response to platelet-derived growth factor. J Biol Chem 2002; 277: 23216-23222.
24. Nakaoka Y, Nishida K, Fujio Y, et al: Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/ docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes. Circ Res 2003; 93: 221-229.
25. Holgado-Madruga M, Wong AJ: Gab1 is an integrator of cell death versus cell survival signals in oxidative stress. Mol Cell Biol 2003; 23: 4471-4484.
26. Yu CF, Liu ZX, Cantley LG: ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase. J Biol Chem 2002; 277: 19382-19388.
27. Isakoff SJ, Cardozo T, Andreev J, et al: Identification and analysis of PH domain-containing targets of phosphatidyl-inositol 3-kinase using a novel in vivo assay in yeast. EMBO J 1998; 17: 5374-5387.
28. Izawa Y, Yoshizumi M, Fujita Y, et al: ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells. Exp Cell Res 2005; 308: 291-299.
29. Kyaw M, Yoshizumi M, Tsuchiya K, et al: Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens Res 2001; 24: 251-261.
30. Kamakura S, Moriguchi T, Nishida E: Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem 1999; 274: 26563-26571.
31. Ishizawa K, Yoshizumi M, Tsuchiya K, et al: Dual effects of endothelin-1 (1-31): induction of mesangial cell migration and facilitation of monocyte recruitment through monocyte chemoattractant protein-1 production by mesangial cells. Hypertens Res 2004; 27: 433-440.
32. Taghibiglou C, Rashid-Kolvear F, Van Iderstine SC, et al: Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J Biol Chem 2002; 277: 793-803.
33. Moroi M, Zhang L, Yasuda T, et al: Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest 1998; 101: 1225-1232.
34. Tsukada S, Iwai M, Nishiu J, et al: Inhibition of experimental intimal thickening in mice lacking a novel G-protein-coupled receptor. Circulation 2003; 107: 313-319.
35. Itoh M, Yoshida Y, Nishida K, Narimatsu M, Hibi M, Hirano T: Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine-induced extracellular signal-regulated kinase mitogen-activated protein kinase activation. Mol Cell Biol 2000; 20: 3695-3704.
36. Zhou G, Bao ZQ, Dixon JE: Components of a new human protein kinase signal transduction pathway. J Biol Chem 1995; 270: 12665-12669.
37. Zhao Q, Egashira K, Hiasa K, et al: Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injury. Arterioscler Thromb Vasc Biol 2004; 24: 2284-2289.
38. Peppel K, Zhang L, Orman ES, et al: Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms. Cardiovasc Res 2005; 65: 674-682.
39. Kingsley K, Huff JL, Rust WL, et al: ERK1/2 mediates PDGF-BB stimulated vascular smooth muscle cell proliferation and migration on laminin-5. Biochem Biophys Res Commun 2002; 293: 1000-1006.
40. Graf K, Xi XP, Yang D, Fleck E, Hsueh WA, Law RE: Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension 1997; 29: 334-339.
41. Cameron SJ, Abe J, Malik S, Che W, Yang J: Differential role of MEK5alpha and MEK5beta in BMK1/ERK5 activation. J Biol Chem 2004; 279: 1506-1512.
42. Ishizawa K, Izawa Y, Ito H, et al: Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation. Hypertension 2005; 46: 1046-1052.
43. Chang Y, Zhuang D, Zhang C, Hassid A: Increase of PTP levels in vascular injury and in cultured aortic smooth muscle cells treated with specific growth factors. Am J Physiol Heart Circ Physiol 2004; 287: H2201-H2208.
44. Kallin A, Demoulin JB, Nishida K, Hirano T, Ronnstrand L, Heldin CH: Gab1 contributes to cytoskeletal reorganization and chemotaxis in response to platelet-derived growth factor. J Biol Chem 2004; 279: 17897-17904.
45. Akaike M, Che W, Marmarosh NL, et al: The hinge-helix 1 region of peroxisome proliferator-activated receptor gamma1 (PPARgamma1) mediates interaction with extracellular signal-regulated kinase 5 and PPARgamma1 transcriptional activation: involvement in flow-induced PPARgamma activation in endothelial cells. Mol Cell Biol 2004; 24: 8691-8704.
46. Wang Y: Fill a Gab(1) in cardiac hypertrophy signaling: search a missing link between gp130 and ERK5 in hypertrophic remodeling in heart. Circ Res 2003; 93: 186-188.
47. Cameron SJ, Itoh S, Baines CP, et al: Activation of big MAP kinase 1 (BMK1/ERK5) inhibits cardiac injury after myocardial ischemia and reperfusion. FEBS Lett 2004; 566: 255-260.